News from the College

  • SAMHSA Grant Aims to Fight Opioid Epidemic through Expansion of Rapid-Access MAT
    June 4, 2019
    The state’s three University of Vermont (UVM) Health Network hospitals are expanding access to treatment for patients with opioid use disorder with the support of a $1.5 million federal grant. The grant will support expansion of a program to offer rapid access to Medication-Assisted Treatment (MAT), such as buprenorphine, for opioid use disorder in the hospitals’ emergency departments.
  • UVM Part of NIH Study of Rural South's Health & Longevity Challenges
    May 22, 2019
    In an effort to understand why some people born in rural communities in the South live shorter and less healthy lives than their counterparts elsewhere in the same counties as well as across the country, researchers from the Larner College of Medicine at the University of Vermont at 11 other institutions will be participating in a new longitudinal cohort study aimed at combating this issue - the Risk Underlying Rural Areas Longitudinal Study (RURAL) .
  • UVM & Dept. of Health Seek Young Vermonters’ Feedback on Substance Use Policies
    May 22, 2019
  • Honors Night Celebrates Senior Medical Student and Faculty Achievements
    May 15, 2019
    The Larner College of Medicine’s Class of 2019 Honors Night on May 13 was all about celebrating achievements. Medical students, leaders, faculty members, family and friends gathered for the event in UVM’s Davis Center to honor the recipients of individual student awards, faculty awards, a staff award, and a department award, as well as recognize the new student inductees for the Alpha Omega Alpha Honor Medical Society and Gold Humanism Honor Society.
  • Gramling Study Explores How Optimism Can Bias Prognosis in Serious Illness
    April 30, 2019
    A new study, published Miller Chair of Palliative Medicine Robert Gramling, M.D., D.Sc., in the journal Psycho-Oncology, details how a seriously ill patient’s optimism can impact a clinician’s survival prognosis in palliative care conversations.
  • Tracy Honored as University Distinguished Professor
    April 26, 2019
    Russell P. Tracy, Ph.D., professor of pathology & laboratory medicine and biochemistry at the Larner College of Medicine at the University of Vermont, is among three faculty members who were selected for recognition as a University of Vermont Distinguished Professor at the UVM Main Commencement ceremony on May 19, 2019.
  • Transitioning to Clerkships: Class of 2021 Takes on Next Level of Training
    April 12, 2019
    After 18 months of active-learning in the classroom, primary care offices around Vermont, and clinical skills sessions in the Clinical Simulation Laboratory at the University of Vermont, the UVM Larner College of Medicine Class of 2021 was excited, if not a bit nervous, to start working more regularly and directly with patients and physicians in clinical settings. This week, as many students in the class started to round out their first clinical rotation, we touched base with them to hear about their expectations, challenges, successes, and takeaways from this next step in their medical education.
  • Larner College of Medicine Faculty Inventions Recognized at Annual I2V Conference
    April 8, 2019
    More than a dozen Larner College of Medicine faculty and scientists were recognized during the awards portion of the 14th annual Invention to Venture (I2V) conference April 5, 2019.
  • Larner Education Team, Med Students Present at 2019 AAMC NEGEA Conference
    April 5, 2019
    Several members of the Larner College of Medicine Teaching Academy staff, Active Learning office and Office of Medical Student Education, as well as medical students from the Social Justice Coalition, are attending and presenting at the 2019 Association of American Medical Colleges Northeast Group on Educational Affairs (NEGEA) conference. The event, which is taking place at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, runs through April 6.
  • Innovative Research Model Sheds Light on Immune Response in Dengue Infection
    March 28, 2019
    Investigators in UVM's Vaccine Testing Center and Center for Translational Global Infectious Disease Research (TGIR) have uncovered details of the human immune response to infection with dengue - a close "cousin" of the Zika virus - which 40 percent of the global population is at risk for contracting. Their study findings were reported recently in the Lancet’s open-access journal EBioMedicine.